Editas Medicine (EDIT) Interest & Investment Income (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Interest & Investment Income data on file, last reported at $1.8 million in Q3 2025.

• On a quarterly basis, Interest & Investment Income fell 48.13% year-over-year to $1.8 million in Q3 2025; TTM through Sep 2025 was $7.8 million, a 56.38% decrease from a year earlier, with the FY2024 full-year figure at $14.1 million, down 19.95% from the prior year.
• Interest & Investment Income for Q3 2025 stood at $1.8 million, down from $2.1 million in the prior quarter.
• Over the last five years, Interest & Investment Income for EDIT reached as high as $5.1 million in Q3 2023 and fell as low as $134000.0 in Q1 2021.
• Historically, Interest & Investment Income has averaged $2.3 million across 5 years, with a median of $2.1 million in 2025.
• Across the five-year window, Interest & Investment Income tumbled 91.4% in 2021 and surged 1449.71% in 2022, its largest moves.
• Year by year, Interest & Investment Income stood at $175000.0 in 2021, then jumped by 1449.71% to $2.7 million in 2022, then jumped by 88.13% to $5.1 million in 2023, then slumped by 76.46% to $1.2 million in 2024, then surged by 52.46% to $1.8 million in 2025.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $1.8 million in Q3 2025, $2.1 million in Q2 2025, and $2.7 million in Q1 2025.